Naman Diagnostic And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 21.90 M
as on 17-07-2024
- Revenue %
(FY 2019)
- Ebitda
- Net Worth -1.03%
(FY 2019)
- Total Assets %
(FY 2019)
About Naman Diagnostic And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.19 Cr.
Shailendra Garg and Ruksana serve as directors at the Company.
- CIN/LLPIN
U85195RJ2001PTC017288
- Company No.
017288
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2001
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Naman Diagnostic And Research Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailendra Garg  | Director | 04-Oct-2006 | Current |
| Ruksana | Director | 31-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Naman Diagnostic And Research Centre.
Naman Diagnostic And Research Centre Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Naman Diagnostic And Research Centre?
In 2018, Naman Diagnostic And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mohan Sons Agrotech Private Limited
Active
18 years 6 months Shailendra Garg and Ruksana are mutual person
Ganpati Mines Private Limited
Active 24 years 11 months Shailendra Garg and Ruksana are mutual person
Glamor Enterprise Private Limited
Active 30 years 5 months Shailendra Garg and Ruksana are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Ltd. Creation Date: 01 Nov 2006 | ₹2.19 Cr | Open |
How Many Employees Work at Naman Diagnostic And Research Centre?
Unlock and access historical data on people associated with Naman Diagnostic And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of May 11, 2009, Naman Diagnostic And Research Centre has raised a total of ₹ 0.8 M, with the most recent deal valued at ₹ 0.4 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
